Theoretically, the inhibitors of PAK1 and PAK2 may also affect vascular function and related diseases [16]; modulating PAK1 and PAK2 activity will be useful in treating dysfunctional vascular problems, such as hypertension, diabetic retinopathy, and cerebrovascular diseases [17]. Here, PAK1 is linked to diabetic retinopathy.